BMC Endocrine Disorders

Table 5 Distribution of malignancy of ACR TI-RADS score and 2015 ATA US patterns for Bethesda III vs IV and V categories in 140 indeterminate thyroid nodules

From: ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology

TBSRTC		2017 ACR TI-RADS score			2015 ATA US patterns
TBSRTC		TR2 / TR3 / TR4a	TR4b / TR4c / TR5	Total	Very low / Low / Intermediate	High	Total
Bethesda III
Histological Result	B	32	5	37	33	4	37
	B	94.1%	50.0%	37	94.3%	45.5%	37
	M	2	5	7	2	5	7
	M	5.9%	50.0%	7	5.7%	55.5%	7
Total		34	10	44	35	9	44
Bethesda IV and Bethesda V
Histological Result	B	28	9	37	31	6	37
	B	40.4%	18.4%	37	63.3%	12.8%	37
	M	19	40	59	18	41	59
	M	59.6%	81.6%	59	36.7%	87.2%	59
Total		47	49	96	49	47	96

Histological Result: B benign and M malignant

Back to article page

ISSN: 1472-6823

Contact us

General enquiries: journalsubmissions@springernature.com